title: An autoregressive linear mixed effects model for the analysis of unequally spaced longitudinal data with dose-modification.
abstract: The assessment of the dose-response relationship is important but not straightforward when the therapeutic agent is administered repeatedly with dose-modification in each patient and a continuous response is measured repeatedly. We recently proposed an autoregressive linear mixed effects model for such data in which the current response is regressed on the previous response, fixed effects, and random effects. The model represents profiles approaching each patient's asymptote, takes into account the past dose history, and provides a dose-response relationship of the asymptote as a summary measure. In an autoregressive model, intermittent missing data mean the missing values in previous responses as covariates. We previously provided the marginal (unconditional on the previous response) form of the proposed model to deal with intermittent missing data. Irregular timings of dose-modification or measurement can also be treated as equally spaced data with intermittent missing values by selecting an adequately small unit of time. The likelihood is, however, expressed by matrices whose sizes depend on the number of observations for a patient, and the computational burden is large. In this study, we propose a state space form of the autoregressive linear mixed effects model to calculate the marginal likelihood without using large matrices. The regression coefficients of the fixed effects can be concentrated out of the likelihood in this model by the same way of a linear mixed effects model. As an illustration of the approach, we analyzed immunologic data from a clinical trial for multiple sclerosis patients and estimated the dose-response curves for each patient and the population mean.
authors.affiliation: Department of Biostatistics, Vanderbilt University School of Medicine, 571 Preston Research Building, Nashville, TN37232-6848, USA. i-funatogawa@umin.ac.jp
authors.forename: Ikuko
authors.initials: I
authors.lastname: Funatogawa
authors.forename: Takashi
authors.initials: T
authors.lastname: Funatogawa
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination / Q000706:statistics & numerical data; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016014:Linear Models; D008137:Longitudinal Studies / Q000706:statistics & numerical data*; D008775:Methylprednisolone / Q000627:therapeutic use; D009103:Multiple Sclerosis / Q000188:drug therapy / Q000453:epidemiology; D016032:Randomized Controlled Trials as Topic / Q000706:statistics & numerical data
chemical_list: D007166:Immunosuppressive Agents; D001379:Azathioprine; D008775:Methylprednisolone